Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content. Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling.
説明 | Apigenin 7-O-methylglucuronide did not affect GAG level or secretion, may potentially be used in osteogenesis imperfecta (OI) type I pharmacotherapy in patients with normal GAG content. Apigenin 7-O-methylglucuronide which normalized collagen synthesis in OI cells may exert their effects through beta1-integrin-mediated signaling. |
植物由来 |
別名 | Apigenin-7-O-β-D-glucuronide methyl ester |
分子量 | 460.39 |
分子式 | C22H20O11 |
CAS No. | 53538-13-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Apigenin 7-O-methylglucuronide 53538-13-9 Apigenin 7 O methylglucuronide Apigenin 7Omethylglucuronide Apigenin-7-O-b-D-glucuronide methyl ester Apigenin-7-O-beta-D-glucuronide methyl ester Apigenin-7-O-β-D-glucuronide methyl ester Inhibitor inhibitor inhibit